The two methods used, i.e., direct cycle Sanger sequencing (BigDye Direct Cycle Sequencing Kit) and NGS panel (Ion AmpliSeq Cancer Hotspot Panel v2) gave identical results detected GNAS pathogenic variant in 83% of the examined myxomas. The gene discussed is GNAS; the disease is myxoma.